medigraphic.com
ISSN 1029-3019 (Electronic)

2013, Number 08

<< Back Next >>

MediSan 2013; 17 (08)

Abnormal vaginal flora and adverse perinatal outcome

Nápoles MD

Language: Spanish
References: 29
Page: 4009-4018
PDF size: 80.36 Kb.


ABSTRACT

Preterm birth and its complications are one of the most important problems in the field of perinatology care. Its close relationship with intrauterine infection has been demonstrated, so that changes of vaginal flora are the gateway. The purpose of this review is to update the medical community of this specialty on the need for identifying bacterial vaginosis and aerobic vaginitis, both at the primary and secondary care, allowing to perform preventive and therapeutic actions on the preconception stage, in order to minimize intrauterine infections and their relation to preterm birth and complications in the short and long term. It is concluded that the diagnosis of both conditions requires a preventive and therapeutic control for reducing perinatal complications.


REFERENCES

  1. The American College of Obstetricians and Gynecologists. Management of preterm labor. Obstet Gynecol. 2012; 119(6):1308-17.

  2. Nápoles Méndez D. Consideraciones sobre el síndrome de respuesta inflamatoria fetal. MEDISAN. 2012 [citado 12 Mar 2013]; 16(11).

  3. Napoles Méndez D. Evaluación del cérvix anteparto: importancia práctica en obstetricia. MEDISAN. 2013 [citado 12 Mar 2013]; 17(5).

  4. Armengol DE. Antibióticos en el tratamiento del parto pretérmino. En: Cabero Roura L. Parto prematuro. Madrid: Editorial Médica Panamericana; 2004. p.175-81.

  5. Donders G, Bellen G, Rezeberga D. Aerobic vaginitis in pregnancy. BJOG. 2011;118(10):1163-70.

  6. Newton ER, Piper J, Peairs W. Bacterial vaginosis and intraamniotic infection. Am J Obstet Gynecol. 1997;176(3):672–7.

  7. Donders GG. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Br J Obstet Gynecol. 2002; 109:1–10.

  8. Mc Donald H, Brocklehurst P, Parsons J, Vigneswaran R. Antibióticos para el tratamiento de la vaginosis bacteriana en el embarazo. En: The Cochrane Library. 2007; Issue 1.

  9. Cauci S, Guaschino S, De Aloysio D, Driussi S, De Santo D, Penacchioni P, et al. Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod. 2003; 9(1):53–8.

  10. Cauci S, Driussi S, Guaschino S, Isola M, Quadrifoglio F. Correlation of local interleukin- 1beta levels with specific IgA response against Gardnerella vaginalis cytolysin in women with bacterial vaginosis. Am J Reprod Immunol 2002; 47(5):257–64.

  11. Massaro G, Scaravilli G, Simeone S, Capuano S, Pastore E, Forte A, et al. Interleukin-6 and Mycoplasma hominis as markers of preterm birth and related brain damage: our experience. J Matern Fetal Neonatal Med. 2009; 22(11):1063-7.

  12. Gómez Mora R. Infección intrauterina y daño neurológico fetal. En: Cabero Roura L. Parto prematuro. Madrid: Editorial Médica Panamericana; 2004. p.77-82.

  13. Carey JC, Klebanoff MA. Is a change in the vaginal flora associated with an increased risk of preterm birth? Am J Obstet Gynecol. 2005; 192(4):1341–6.

  14. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007; 24(1):CD000262.

  15. Lamont RF. El papel de la infección en la etiología y predicción del parto pretérmino. En: Cabero Roura L. Parto prematuro. Madrid: Editorial Médica Panamericana; 2004. p. 53- 63.

  16. Romero R, Gotsch F, Pineles B, Kusanovic JP. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev. 2007; 65(12 Pt 2):S194–202.

  17. Donders GG, Van Calsteren C, Bellen G, Reybrouck R, Van Den Bosch T, Riphagen I, et al. Association between abnormal vaginal flora and cervical length as risk factors for preterm birth. Ultrasound Obstet Gynecol. 2010 [citado 12 Mar 2013]; 26

  18. Mumtaz S, Ahmad M, Aftab I, Akhtar N, ul Hassan M, Hamid A. Aerobic vaginal pathogens and their sensitivity pattern. J Ayub Med Coll Abbottabad. 2008;20(1):113–7.

  19. Madhivanan P, Krupp K, Hardin J, Karat C, Klausner JD, Reingold AL. Simple and inexpensive point-of-care tests improve diagnosis of vaginal infections in resource constrained settings. Trop Med Int Health. 2009;14(6):703–8.

  20. Ortega Soler C, Castaño R, Copolillo E, Kwiatkowski L, Lotoczko V, Tilli M. Guía práctica integral (clínica-laboratorio) de diagnóstico de vaginosis-vaginitis en la atención primaria de la mujer en edad fértil. Acta Bioquim Clin Latinoam. 2010;44(3):359-69.

  21. Daoud GA, Suzuki Y, Yamamoto T, Suzuki T, Suzumori N, Tanemura M. Establishment of a polymerase chain reaction method for detection of Escherichia coli in amniotic fluid in patients with chorioamnionitis. Fetal Diagn Ther. 2008;24(2):132–9.

  22. López Abraham AM, Delgado Delgado I, Iglesias Pérez E, Romero Céspedes M, Espinosa Castaño I, Fernández Masso JR. Evaluación de un método de aglutinación con partículas látex sensibilizadas para el diagnóstico de Gardnerella vaginalis. Rev Cubana Med Trop. 2008 [citado 12 Mar 2013]; 60(2).

  23. Di Bartolomeo S, Leonino AP, Rodríguez Fermepin M, de Torres RA. Balance del contenido vaginal en el diagnóstico diferencial de vaginosis-vaginitis. Reacción inflamatoria vaginal en embarazadas sintomáticas. Acta Bioquim Clin Latinoam. 2007 [citado 12 Mar 2013]; 41(2).

  24. Blue Oehler G, Heesemann J, Kranzfelder D, Scheutz F, Hacker J. Characterization of Escherichia coli serotype O12:K1:H7 isolates from an immunocompetent carrier with a history of spontaneous abortion and septicemia. Eur J Clin Microbiol Infect Dis. 1997; 16(2):153–5.

  25. Lobos O, Padilla C. Phenotypic characterization and genomic DNA polymorphisms of Escherichia coli strains isolated as the sole micro-organism from vaginal infections. Microbiology. 2009; 155(Pt 3):825–30.

  26. Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol. 2003; 101(5 Pt 1):847–55.

  27. Tempera G, Bonfiglio G, Cammarata E, Corsello S, Cianci A. Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study. Int J Antimicrob Agents. 2004; 24(1):85–8.

  28. Salcedo Abizanda S, Ruiz Campillo C. Repercusiones neonatales de la prematuridad. En: Cabero Roura L. Parto prematuro. Madrid: Editorial Médica Panamericana; 2004. p.19- 31.

  29. Aleman Mondeja LD, Almanza Martinez C, Fernández Limia O. Diagnóstico y prevalencia de infecciones vaginales. Rev Cubana Obstet Ginecol. 2010 [citado 12 Mar 2013]; 36(2).




2020     |     www.medigraphic.com